Search Results for "AzaSite"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for AzaSite. Results 1 to 3 of 3 total matches.
See also: azithromycin

Ophthalmic Azithromycin (AzaSite)

   
The Medical Letter on Drugs and Therapeutics • Feb 11, 2008  (Issue 1279)
Ophthalmic Azithromycin (AzaSite) ...
The FDA has approved azithromycin 1% ophthalmic solution (AzaSite - Inspire) for treatment of bacterial conjunctivitis in patients > 1 year old. It is formulated, according to the manufacturer, in a controlled-release delivery system that keeps the drug in the eye for several hours.
Med Lett Drugs Ther. 2008 Feb 11;50(1279):11-2 |  Show IntroductionHide Introduction

Ophthalmic Besifloxacin (Besivance)

   
The Medical Letter on Drugs and Therapeutics • Dec 14, 2009  (Issue 1327)
, it has no demonstrated clinical advantage over older, less expensive drugs. 1. Ophthalmic azithromycin (AzaSite). Med ...
The FDA has approved the fluoroquinolone besifloxacin 0.6% ophthalmic suspension (Besivance - Bausch & Lomb) for treatment of bacterial conjunctivitis caused by susceptible bacteria. According to the manufacturer, this product was developed specifically for ophthalmic use in a specialized vehicle designed to prolong contact time on the ocular surface. Besifloxacin is not available for systemic use.
Med Lett Drugs Ther. 2009 Dec 14;51(1327):101-3 |  Show IntroductionHide Introduction

Drugs for Common Eye Disorders

   
The Medical Letter on Drugs and Therapeutics • Dec 02, 2019  (Issue 1586)
. Ophthalmic azithromycin (AzaSite). Med Lett Drugs Ther 2008; 50:11. 32. Ophthalmic besifloxacin (Besivance ...
This issue includes reviews of drugs for glaucoma, age-related macular degeneration (AMD), bacterial conjunctivitis, and dry eye disease. Allergic conjunctivitis is reviewed in a separate issue.
Med Lett Drugs Ther. 2019 Dec 2;61(1586):187-94 |  Show IntroductionHide Introduction